Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The quest to prevent MS — and understand other post-viral diseases

Some people develop multiple sclerosis after an infection. Could a vaccine prevent that — and what does it reveal about the long-term effects of viruses?
  1. Asher Mullard

    1. Asher Mullard is a science journalist based in Ottawa, Canada.

    View author publications

    You can also search for this author in PubMed  Google Scholar

False coloured transmission electron micrograph of Epstein-Barr virus

A small number of people infected with Epstein-Barr virus (pictured) go on to develop multiple sclerosis years later. Credit: Dr Gopal Murti/SPL

In a sprawling facility in Silver Spring, Maryland, the US Department of Defense (DoD) has amassed a hoard of epidemiological treasure. Walk-in freezers each the size of a basketball court hold 72 million vials of blood serum meticulously tracked and sorted into cardboard boxes stacked nearly 4 metres high. Technicians pull on winter coats and gloves for 20-minute trips into these −30 °C deep freezers. The vials they bring out hold untold riches.

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature 603, 784-786 (2022)

doi: https://doi.org/10.1038/d41586-022-00808-x

Updates & Corrections

  • Clarification 07 April 2022: An earlier version of this story stated that Katherine Luzuriaga is the lead investigator on the mRNA-1189 trial. She is, in fact, the lead investigator only for the UMass Chan part of the trial.

References

  1. Bjornevik, K. et al. Science 375, 296–301 (2022).

    Article  PubMed  Google Scholar 

  2. Lanz, T. V. et al. Nature 603, 321–327 (2022).

    Article  PubMed  Google Scholar 

  3. Cohen, J. I. Clin. Transl. Immunol. 4, e32 (2015).

    Article  Google Scholar 

  4. Luzuriaga, K. & Sullivan, J. L. N. Engl. J. Med. 362, 1993–2000 (2010).

    Article  PubMed  Google Scholar 

  5. Messick, T. E. et al. Sci. Transl. Med. 11, eaau5612 (2019).

    Article  PubMed  Google Scholar 

  6. Lebrun-Frenay, C. et al. Ann. Neurol. 88, 407–417 (2020).

    Article  PubMed  Google Scholar 

  7. Douaud, G. et al. Nature https://doi.org/10.1038/s41586-022-04569-5 (2022).

    Article  Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links